The table below shows Cue Biopharma, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$5.69M
$2.15M
$2.95M
$421.00K
$3.34M
$2.66M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$6.90M
$4.75M
$7.91M
$8.55M
$9.38M
$9.53M
SG&A
CUE annual revenue (10-K history)
Cue Biopharma, Inc. reported annual revenue of $27.47M for fiscal year 2025. That is up 195.7% from $9.29M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $1.14M (FY 2018) to $27.47M. Figures come from the company's audited annual reports as filed with the SEC.